Caprock Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $909K | Sell |
18,862
-16,034
| -46% | -$748K | 0.02% | 572 |
|
|
2025
Q4 | $1.69M | Buy |
34,896
+7,667
| +28% | +$380K | 0.04% | 439 |
|
|
2025
Q3 | $1.35M | Buy |
+27,229
| New | +$1.31M | 0.03% | 468 |
|
|
2025
Q1 | $1.63M | Buy |
29,384
+7,273
| +33% | +$394K | 0.05% | 348 |
|
|
2024
Q4 | $1.07M | Sell |
22,111
-1,839
| -8% | -$93.5K | 0.03% | 404 |
|
|
2024
Q3 | $1.38M | Sell |
23,950
-7,166
| -23% | -$387K | 0.05% | 317 |
|
|
2024
Q2 | $1.51M | Buy |
31,116
+8,502
| +38% | +$410K | 0.06% | 278 |
|
|
2024
Q1 | $1.1M | Sell |
22,614
-1,465
| -6% | -$71.5K | 0.06% | 227 |
|
|
2023
Q4 | $1.2M | Buy |
24,079
+878
| +4% | +$42.9K | 0.08% | 212 |
|
|
2023
Q3 | $1.24M | Buy |
23,201
+2,567
| +12% | +$137K | 0.09% | 167 |
|
|
2023
Q2 | $1.11M | Buy |
20,634
+1,615
| +8% | +$86.9K | 0.08% | 196 |
|
|
2023
Q1 | $1.04M | Buy |
19,019
+2,923
| +18% | +$142K | 0.08% | 192 |
|
|
2022
Q4 | $780K | Buy |
16,096
+4,167
| +35% | +$183K | 0.07% | 207 |
|
|
2022
Q3 | $454K | Sell |
11,929
-4,992
| -30% | -$222K | 0.04% | 296 |
|
|
2022
Q2 | $847K | Sell |
16,921
-166
| -1% | -$8.81K | 0.08% | 177 |
|
|
2022
Q1 | $877K | Buy |
17,087
+6,611
| +63% | +$341K | 0.08% | 199 |
|
|
2021
Q4 | $525K | Buy |
10,476
+1,221
| +13% | +$60.4K | 0.04% | 278 |
|
|
2021
Q3 | $446K | Sell |
9,255
-474
| -5% | -$24.1K | 0.04% | 285 |
|
|
2021
Q2 | $512K | Sell |
9,729
-172
| -2% | -$8.98K | 0.05% | 253 |
|
|
2021
Q1 | $490K | Buy |
9,901
+1,460
| +17% | +$70.1K | 0.05% | 245 |
|
|
2020
Q4 | $410K | Sell |
8,441
-19
| -0.2% | -$937 | 0.05% | 262 |
|
|
2020
Q3 | $424K | Buy |
8,460
+35
| +0.4% | +$1.8K | 0.06% | 235 |
|
|
2020
Q2 | $430K | Sell |
8,425
-2,370
| -22% | -$115K | 0.06% | 211 |
|
|
2020
Q1 | $472K | Buy |
10,795
+1,007
| +10% | +$48.2K | 0.09% | 161 |
|
|
2019
Q4 | $491K | Buy |
9,788
+475
| +5% | +$22.3K | 0.09% | 165 |
|
|
2019
Q3 | $431K | Buy |
9,313
+1,565
| +20% | +$67.5K | 0.08% | 177 |
|
|
2019
Q2 | $335K | Sell |
7,748
-602
| -7% | -$25.6K | 0.07% | 220 |
|
|
2019
Q1 | $370K | Buy |
8,350
+214
| +3% | +$9.17K | 0.07% | 219 |
|
|
2018
Q4 | $353K | Buy |
8,136
+2,058
| +34% | +$90.8K | 0.08% | 204 |
|
|
2018
Q3 | $272K | Buy |
6,078
+276
| +5% | +$11.8K | 0.06% | 296 |
|
|
2018
Q2 | $232K | Sell |
5,802
-180
| -3% | -$7.09K | 0.05% | 349 |
|
|
2018
Q1 | $240K | Sell |
5,982
-75
| -1% | -$3.12K | 0.05% | 340 |
|
|
2017
Q4 | $271K | Sell |
6,057
-322
| -5% | -$14.8K | 0.05% | 329 |
|
|
2017
Q3 | $318K | Buy |
6,379
+508
| +9% | +$24.6K | 0.07% | 270 |
|
|
2017
Q2 | $281K | Buy |
+5,871
| New | +$281K | 0.06% | 295 |
|
|
2016
Q2 | – | Sell |
-5,414
| Closed | -$217K | – | 342 |
|
|
2016
Q1 | $217K | Buy |
+5,414
| New | +$218K | 0.05% | 294 |
|
Other funds holding SNY
MIP
Caprock Group's SNY Position: Q1 2026 in Review
Caprock Group reduced its Sanofi (SNY) stake by 46% in Q1 2026, selling an estimated $748K and leaving 18,862 shares worth $909K. The position accounts for 0.02% of the portfolio, ranked #572.
Caprock Group first reported a position in SNY in Q1 2016 and has held it in 36 quarters since. The position peaked at $1.69M in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Caprock Group held 18,862 shares of Sanofi worth $909K as of Q1 2026.
- Caprock Group sold 16,034 Sanofi shares in Q1 2026, an estimated $748K.
- Sanofi made up 0.02% of Caprock Group's portfolio in Q1 2026, its #572 holding.
- Caprock Group first reported a position in Sanofi in Q1 2016 and has held it in 36 quarters since.
- Caprock Group's Sanofi position peaked at $1.69M in Q4 2025.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.